Clinical Trials Directory

Trials / Completed

CompletedNCT01412320

Cocoa Flavanols in Renal Disease

The Impact of Dietary Flavanols on Cardiovascular Dysfunction in End-stage Renal Disease

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose of the study is to characterize the potential acute and long-term improvement of dietary flavanols on vascular function in patients with end-stage renal disease (ESRD). Patients will twice daily receive either a flavanol-poor or a flavanol-rich drink. In a double blind, placebo-controlled crossover study the safety, efficacy and acute beneficial effects of flavanol ingestion will be assessed in 10 patients with ESRD. In a 30 day long-term, double blind, placebo-controlled parallel study the chronic effects of dietary flavanols on vascular function in 52 patients with ESRD will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERCocoadissolved in water twice daily
OTHERCocoadissolved in water twice daily

Timeline

Start date
2011-08-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-08-09
Last updated
2013-11-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01412320. Inclusion in this directory is not an endorsement.